MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
OPY stock logo

OPY

Oppenheimer Holdings Inc.

$90.95
1.36
 (1.52%)
Exchange:  NYSE
Market Cap:  964.76M
Shares Outstanding:  11.2M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Financial Services
Industry:  Financial – Capital Markets
   
CEO:  Robert Steven Lowenthal
Full Time Employees:  2974
Address: 
85 Broad Street
New York City
NY
10004
US
Website:  https://www.oppenheimer.com
Oppenheimer Holdings Inc., through its subsidiaries, operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia. The company offers brokerage services covering exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services; and margin lending services. It also provides asset management services, including separately managed accounts, mutual fund managed accounts, discretionary portfolio management programs, non-discretionary investment advisory and consultation services, alternative investments, portfolio enhancement programs, and institutional taxable fixed income portfolio management strategies and solutions, as well as taxable and non-taxable fixed income portfolios and strategies. In addition, the company offers investment banking services, such as strategic advisory services and capital markets products; merger and acquisition, equities capital market, and debt capital market products and services; and institutional equity sales and trading, equity research, equity derivatives and index options, convertible bonds, and trading services. Further, it provides institutional fixed income sales and trading, fixed income research, public finance, and municipal trading services; repurchase agreements and securities lending services; and proprietary trading and investment activities. Additionally, the company offers underwritings, market-making, trust, and discount services. It serves high-net-worth individuals and families, corporate executives, public and private businesses, institutions and corporations, governments, financial sponsors, and domestic and international investors. Oppenheimer Holdings Inc. was founded in 1881 and is headquartered in New York, New York.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue1,248,8251,432,4961,638,071
Gross Profit441,501468,041837,868
EBITDA152,574231,033277,612
Operating Income284,178304,828367,499
Net Income30,17971,557148,403

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets2,874,8163,382,7260
Total Liabilities2,085,5772,532,331-920,274
Total Stockholders Equity789,166850,395920,274
Total Debt945,315687,5880
Cash and Cash Equivalents28,83533,1500

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-18,810-108,1680
Capital Expenditure-17,056-5,1480
Free Cash Flow-35,866-113,3160
Net Income30,17971,557148,403
Net Change in Cash-109,1324,315-33,150

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)914,626Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)914,626Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)914,626Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)135,192.749Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)135,192.749Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)135,192.749Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)28,442.610Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)28,442.610Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)28,442.610Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)138,797.307Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)138,797.307Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)138,797.307Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)2.490Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)2.490Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)2.490Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)1Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
1.429B  ?P/S
 (TTM)
: 
0.74
?Net Income
 (TTM)
: 
71.557M  ?P/E
 (TTM)
: 
8.07
?Enterprise Value
 (TTM)
: 
1.799B  ?EV/FCF
 (TTM)
: 
9.8
?Dividend Yield
 (TTM)
: 
0.02  ?Payout Ratio
 (TTM)
: 
0.05
?ROE
 (TTM)
: 
0.16  ?ROIC
 (TTM)
: 
0.08
?Net Debt
 (TTM)
: 
1.346B  ?Debt/Equity
 (TTM)
: 
0.64
?P/B
 (TTM)
: 
1.22  ?Current Ratio
 (TTM)
: 
5.99

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
109.58Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate OPY Intrinsic Value

Common questions about OPY valuation

Is Oppenheimer Holdings Inc. (OPY) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Oppenheimer Holdings Inc. (OPY) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is OPY a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether OPY trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is OPY’s P/E ratio?

You can see OPY’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for OPY?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is OPY a good long-term investment?

Whether OPY fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

OPY

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1.52
MARKETSnap

Trading Metrics:

Open: 88.33   Previous Close: 89.59
Day Low: 87.93   Day High: 91.28
Year Low: 49.26   Year High: 94.1
Price Avg 50: 86.02   Price Avg 200: 74.81
Volume: 28430   Average Volume: 58201

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Oppenheimer Expands Municipal Capital Markets Platform with Three Managing Director Hires
31-03-2026 09:00
Oppenheimer Expands Municipal Capital Markets Platform with Three Managing Director Hires
Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference
Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript
Actuate Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Cross Country Healthcare to Attend the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare Medtech & Services Conference
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read